Skip to content
MadMax

Maxime Marquette

Independent columnist · MadMax

MadMax is an independent bilingual news outlet based in Québec, publishing analysis on geopolitics, technology, democracy, and culture.

Our mission: rigorous, source-cited analysis carried out with full editorial independence — no sponsorship, no party line.

Our editorial standards: sources are cited inline, corrections are fixed and logged publicly, and any use of artificial intelligence is disclosed.

Fire first

“Burn rather than rot. Write rather than stay silent.”

Write as if burning

Fire first. Sentences after. No lukewarm takes.

Raw truth

Always answer the strongest version of the opposing point. No strawmen.

Independence

No commissioned pieces. No editorial masters. No compromise.

Columns by Maxime Marquette

4,540 columns published
Open letter· No. 2101

XAI launches Voice Agent Builder, the voice becomes a commodity

Introduction: when the human voice becomes a software module

Profile· No. 2100

AI giants' $500 million bet to fix the jobs they are destroying

Introduction: a check against a wave

Reportage· No. 2099

Rheinmetall finalizes DOK-ING acquisition to strengthen autonomous systems

Introduction: a deal that closes a strategic chapter

Essay· No. 2098

Trump wins expanded power to fire independent regulators

Introduction: a 91-year-old precedent swept away in one morning

Column· No. 2097

Supreme Court upholds bans on transgender athletes in school sports

Introduction: a decision Washington had awaited for months

Note· No. 2096

Glasgow 2026 enters the final countdown before the Commonwealth Games

Introduction: twenty days before Scotland's big moment

Profile· No. 2095

Nine Democratic governors take on the Postal Service over Trump's election order

Introduction: a six-page letter that denounces a presidential overreach

Investigation· No. 2094

Musk cries foul after report reveals secret SpaceX AI phone

Introduction: an "utterly false" that convinces no one

Commentary· No. 2093

Anthropic wades into drug discovery for neglected diseases

Introduction: when an artificial intelligence company becomes an apprentice pharmacist